Literature DB >> 2001923

Retinal ganglion cell loss is size dependent in experimental glaucoma.

Y Glovinsky1, H A Quigley, G R Dunkelberger.   

Abstract

Thirty-two areas located in the temporal midperipheral retina were evaluated in whole-mount preparations from four monkeys with monocular experimental glaucoma. Diameter frequency distributions of remaining ganglion cells in the glaucomatous eye were compared with corresponding areas in the normal fellow eye. Large cells were significantly more vulnerable at each stage of cell damage as determined by linear-regression analysis. The magnitude of size-dependent loss was moderate at an early stage (20% loss), peaked at 50% total cell loss, and decreased in advanced damage (70% loss). In glaucomatous eyes, the lower retina had significantly more large cell loss than the corresponding areas of the upper retina. In optic nerve zones that matched the retinal areas studied, large axons selectively were damaged first. Psychophysical testing aimed at functions subserved by larger ganglion cells is recommended for detection and follow-up of early glaucoma; however, assessment of functions unique to small cells is more appropriate for detecting change in advanced glaucoma.

Entities:  

Mesh:

Year:  1991        PMID: 2001923

Source DB:  PubMed          Journal:  Invest Ophthalmol Vis Sci        ISSN: 0146-0404            Impact factor:   4.799


  100 in total

Review 1.  A hypothesis to explain ganglion cell death caused by vascular insults at the optic nerve head: possible implication for the treatment of glaucoma.

Authors:  N N Osborne; J Melena; G Chidlow; J P Wood
Journal:  Br J Ophthalmol       Date:  2001-10       Impact factor: 4.638

2.  A comparison of perimetric results with the Medmont and Humphrey perimeters.

Authors:  J Landers; A Sharma; I Goldberg; S Graham
Journal:  Br J Ophthalmol       Date:  2003-06       Impact factor: 4.638

3.  Blood flow per unit retinal nerve fibre tissue volume is lower in the human inferior retina.

Authors:  A Harris; Y Ishii; H S Chung; C P Jonescu-Cuypers; L J McCranor; L Kagemann; H J Garzozi
Journal:  Br J Ophthalmol       Date:  2003-02       Impact factor: 4.638

4.  Psychophysical characterisation of early functional loss in glaucoma and ocular hypertension.

Authors:  E A Ansari; J E Morgan; R J Snowden
Journal:  Br J Ophthalmol       Date:  2002-10       Impact factor: 4.638

5.  Visual evoked cortical potentials from transient dark and bright stimuli. Selective 'on' and 'off-pathway' testing?

Authors:  E Mutlukan; M Bradnam; D Keating; B E Damato
Journal:  Doc Ophthalmol       Date:  1992       Impact factor: 2.379

6.  Quantitative measurement of retinal ganglion cell populations via histology-based random forest classification.

Authors:  Adam Hedberg-Buenz; Mark A Christopher; Carly J Lewis; Kimberly A Fernandes; Laura M Dutca; Kai Wang; Todd E Scheetz; Michael D Abràmoff; Richard T Libby; Mona K Garvin; Michael G Anderson
Journal:  Exp Eye Res       Date:  2015-10-22       Impact factor: 3.467

7.  Effect of eccentricity on pattern-pulse multifocal VEP.

Authors:  Alexander I Klistorner; Stuart L Graham
Journal:  Doc Ophthalmol       Date:  2005 Mar-May       Impact factor: 2.379

8.  Ganglion cell loss and age-related visual loss: a cortical pooling analysis.

Authors:  Pauline M Pearson; Laura A Schmidt; Emily Ly-Schroeder; William H Swanson
Journal:  Optom Vis Sci       Date:  2006-07       Impact factor: 1.973

9.  Characterization of retinal damage in the episcleral vein cauterization rat glaucoma model.

Authors:  John Danias; Fran Shen; Manolis Kavalarakis; Bin Chen; David Goldblum; Kevin Lee; Maria-Florencia Zamora; YanLing Su; Scott E Brodie; Steven M Podos; Thom Mittag
Journal:  Exp Eye Res       Date:  2005-08-16       Impact factor: 3.467

10.  Nuclear atrophy of retinal ganglion cells precedes the bax-dependent stage of apoptosis.

Authors:  Katherine T Janssen; Caitlin E Mac Nair; Joel A Dietz; Cassandra L Schlamp; Robert W Nickells
Journal:  Invest Ophthalmol Vis Sci       Date:  2013-03-11       Impact factor: 4.799

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.